Axtria Blogs

Pharma Commercial Models

Covid-19 impact on Pharma Commercial Models

Impact of COVID-19 on the Commercial Models of Pharmaceutical Companies in the US


“The Chinese use two brush strokes to write the word 'crisis.' One brush stroke stands for danger; the other for opportunity. In a crisis, be aware of the danger--but recognize the opportunity.” 

John F Kennedy

The US pharmaceutical industry, which is racing to develop a vaccine to beat the novel coronavirus, is facing never-before-seen challenges. The hurdles include public policy mandates (e.g., shelter-in-place orders and closing of non-essential businesses) and sweeping restrictions placed on industry representatives from entering offices and hospitals to meet healthcare professionals (HCPs). These policy mandates and restrictions are causing pharmaceutical companies to rethink their go-to-market strategy.

Read More

Let Us Show You What Axtria’s 

Solutions Can Do For You